Prognostic assessment of IgA nephropathy: how much does histology add?

被引：5
|
作者：
Floege, Juergen [1 ]
机构：
[1] Rhein Westfal TH Aachen, Div Nephrol & Immunol, D-52057 Aachen, Germany
来源：
KIDNEY INTERNATIONAL | 2016年 / 89卷 / 01期
关键词：
OXFORD CLASSIFICATION; VALIDATION;
D O I：
10.1016/j.kint.2015.11.005
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
IgA nephropathy exhibits a widely varying clinical course from asymptomatic urinary abnormalities to rapidly progressive renal failure. Determining the prognosis based on parameters obtained very early in the course of disease is of central importance in clinical decision making. Barbour et al. assessed whether adding biopsy findings to clinical parameters obtained at first presentation improves the predictive power. (C) 2016 International Society of Nephrology
引用
收藏
页码：19 / 21
页数：3
相关论文
共 50 条
  • [21] Epidemiological, clinical and prognostic indices in IgA nephropathy
    DAmico, G
    NEPHROLOGY, 1997, 3 (01) : 13 - 17
  • [22] Prognostic significance of circulating microparticles in IgA nephropathy
    Niharika Bharti
    Mohit Kumar Rai
    Snigdha Singh
    Vikas Agarwal
    Narayan Prasad
    Rakesh Pandey
    Vinita Agrawal
    International Urology and Nephrology, 2024, 56 : 1071 - 1081
  • [23] ANCA AND IGA NEPHROPATHY: ASSOCIATION OR PROGNOSTIC FACTOR
    Ben Mahmoud, Nouha
    Ben Salem, Meriem
    Ben Salah, Manel
    Letaief, Ahmed
    Hammouda, Mouna
    Sabra, Aloui
    Skhiri, Habib
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1146 - I1146
  • [24] Development and validation of a prognostic nomogram for IgA nephropathy
    Liu, Jian
    Duan, Shuwei
    Chen, Pu
    Cai, Guangyan
    Wang, Yong
    Tang, Li
    Liu, Shuwen
    Zhou, Jianhui
    Wu, Di
    Shen, Wanjun
    Chen, Xiangmei
    Wu, Jie
    ONCOTARGET, 2017, 8 (55) : 94371 - 94381
  • [25] IGA NEPHROPATHY - CLINICAL AND HISTOLOGICAL PROGNOSTIC FACTORS
    Huerta, Ana
    Bomback, Andrew S.
    Canetta, Pietro A.
    Radhakrishnan, Jai
    Herlitz, Leal
    Stokes, Barry
    D'agati, Vivette
    Markowitz, Glen
    Appel, Gerald B.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 190 - 190
  • [26] Prognostic significance of circulating microparticles in IgA nephropathy
    Bharti, Niharika
    Rai, Mohit Kumar
    Singh, Snigdha
    Agarwal, Vikas
    Prasad, Narayan
    Pandey, Rakesh
    Agrawal, Vinita
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (03) : 1071 - 1081
  • [27] Smoking aggravates renal function and histology in IgA nephropathy patients
    Jeong, H. -J.
    Cha, Y. -J.
    Kim, Y. -H.
    Lim, B. -J.
    VIRCHOWS ARCHIV, 2014, 465 : S263 - S263
  • [28] PROGNOSTIC INDICATORS IN IDIOPATHIC IGA MESANGIAL NEPHROPATHY
    DAMICO, G
    MINETTI, L
    PONTICELLI, C
    FELLIN, G
    FERRARIO, F
    DIBELGIOIOSO, GB
    IMBASCIATI, E
    RAGNI, A
    BERTOLI, S
    FOGAZZI, G
    DUCA, G
    QUARTERLY JOURNAL OF MEDICINE, 1986, 59 (228): : 363 - 378
  • [29] Prognostic Factors and Therapy Assessment of IgA Nephropathy: Report from a Single Unit in Iran
    Soleymanian, Tayebeh
    Najafi, Iraj
    Salimi, Bahare Haji
    Broomand, Behrooz
    RENAL FAILURE, 2011, 33 (06) : 572 - 577
  • [30] How much does HDL cholesterol add to risk estimation? A report from the SCORE investigators
    Cooney, Marie Therese
    Dudina, Alexandra
    De Bacquer, Dirk
    Fitzgerald, Anthony
    Conroy, Ronan
    Sans, Susana
    Menotti, Alessandro
    De Backer, Guy
    Jousilahti, Pekka
    Keil, Ulrich
    Thomsen, Troels
    Whincup, Peter
    Graham, Ian
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2009, 16 (03): : 304 - 314
12345